Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jan;88(1):88-96.
doi: 10.1111/j.1349-7006.1997.tb00306.x.

Establishment by adriamycin exposure of multidrug-resistant rat ascites hepatoma AH130 cells showing low DT-diaphorase activity and high cross resistance to mitomycins

Affiliations

Establishment by adriamycin exposure of multidrug-resistant rat ascites hepatoma AH130 cells showing low DT-diaphorase activity and high cross resistance to mitomycins

S Wakusawa et al. Jpn J Cancer Res. 1997 Jan.

Abstract

A resistant subline (AH130/5A) selected from rat hepatoma AH130 cells after exposure to adriamycin (ADM) showed remarkable resistance to multiple antitumor drugs, including mitomycin C (MMC) and porfiromycin (PFM). PFM, vinblastine (VLB), and ADM accumulated in AH130/5A far less than in the parent AH130 (AH130/P) cells. AH130/5A cells showed overexpression of P-glycoprotein (PGP), an increase in glutathione S-transferase activity, and a decrease in DT-diaphorase and glutathione peroxidase activity. The resistance to MMC and VLB of AH130/5A cells was partly reversed by H-87, an inhibitor of PGP. Buthionine sulfoximine, an inhibitor of glutathione synthase, did not affect the action of MMC. tert-Butylhydroquinone induced DT-diaphorase activity, increased PFM uptake, and enhanced the growth-inhibitory action of MMC in AH130/5A cells. Dicumarol, an inhibitor of DT-diaphorase, decreased PFM uptake and reduced the growth-inhibitory action of MMC in AH130/P cells. These results indicated that the adriamycin treatment of hepatoma cells caused multifactorial multidrug resistance involving a decrease in DT-diaphorase activity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. ) Tsuruo , T. , Iida‐Saito , H. , Kawabata , H. , Ohhara , H. , Hamada , H. and Utakoji , T.Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to Adriamycin and in isolated clones . Jpn. J. Cancer Res. , 77 , 682 – 692 ( 1986. ). - PubMed
    1. ) Hagiwara , M. , Wakusawa , S. , ‐Miyamoto , K. and Hidaka , H.Obviation of drug resistance and affinity purification of P‐glycoprotein by isoquinolinesulfonamides . Cancer Lett. , 60 , 103 – 107 ( 1991. ). - PubMed
    1. ) Mizuno , K. , Furuhashi , Y. , Maeda , O. , Iwata , M. , Misawa , T. , Kawai , M. , Kano , T. and Tomoda , Y.Mitomycin C cross‐resistance induced by adriamycin in human ovarian cancer cells in vitro . Cancer Chemother. Pharmacol , 26 , 333 – 339 ( 1990. ). - PubMed
    1. ) Chen , Y. N. , Mickley , L. A. , Schwartz , A. M. , Acton , E. M. , Hwang , J. L. and Fojo , A. T.Characterization of adriamycin‐resistant human breast cancer cells which display overexpression of a novel resistance‐related membrane protein . J. Biol. Chem. , 265 , 10073 – 10080 ( 1990. ). - PubMed
    1. ) Scheper , R. J. , Broxtermann , H. J. , Scheffer , G. L. , Kaaijk , P. , Dalton , W. S. , van Heijinigen , T. H. M. , van Kalken , C. K. , Slovak , M. L. , de Vries , E. G. E. , van der Valk , P. , Meijer , C. J.L. M. and Pinedo , H. M.Overexpression of a Mr110,000 vesicular protein in non‐P‐glycoprotein‐mediated multidrug resistance . Cancer Res. 53 , 1475 – 1479 ( 1993. ). - PubMed

MeSH terms

Substances

LinkOut - more resources